Neximmune to present at the barclays 2022 global healthcare conference

Gaithersburg, md., march 10, 2022 (globe newswire) -- neximmune, inc. (nasdaq: nexi), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells, today announced that kristi jones, chief executive officer, will present at the barclays 2022 global healthcare conference on thursday, march 17, 2022 at 8:30 a.m. eastern time.
NEXI Ratings Summary
NEXI Quant Ranking